Suppr超能文献

中国林奇综合征家系错配修复基因突变分析及结肠镜监测

Mismatch repair gene mutation analysis and colonoscopy surveillance in Chinese Lynch syndrome families.

机构信息

Department of Gastroenterology, Third Military Medical University and General Hospital of Beijing Military Region, Chongqing, 400038, China.

出版信息

Cell Oncol (Dordr). 2013 Jun;36(3):225-31. doi: 10.1007/s13402-013-0130-z. Epub 2013 May 3.

Abstract

BACKGROUND

Lynch syndrome (or HNPCC) is a colorectal cancer syndrome caused by germline mutations in either one of the DNA mismatch repair (MMR) genes hMLH1, hMSH2, hMSH6 or hPMS2. Mutations in hMLH1 and hMSH2 are most prevalent. Here we aimed to determine the cancer risk of MMR gene mutation carriers and, in addition, the efficacy of colonoscopy surveillance in Chinese Lynch syndrome family members with and without MMR gene mutations.

METHODS

A Lynch syndrome family registry encompassing 106 families in Northern China was recently established. Detailed pedigree data for each family were collected and hMLH1 and hMSH2 gene mutation analyses were performed. Germ-line mutations were identified in probands from 42 of these families, and additional genetic analyses were performed in each member of these 42 families to identify mutation and non-mutation carriers. Among the family members included, 180 received colonoscopy and the remaining cases were followed without colonoscopy.

RESULTS

Overall 54.8 % of the Lynch syndrome family members carried MMR gene mutations, and these mutation carriers exhibited significantly higher colorectal cancer and other Lynch syndrome-associated cancer risks as compared to non-mutation carriers. The cumulative risk for all Lynch syndrome-related cancers at age 70 was 93.8 % for both hMLH1 and hMSH2 mutation carriers, and 81.7 % and 93.1 % for colorectal cancer at this age, respectively. Whereas 43 of 102 (42.2 %) mutation carriers exhibited significant colonoscopy findings, including 10 colorectal cancers, none of 78 non-mutation carriers exhibited significant findings, and no cancers were detected. In addition, in the mutation carriers, colonoscopy surveillance led to the detection of more early stage cancers than in the non-surveillance group (70.0 % versus 36.5 %, p < 0.01).

CONCLUSION

In Lynch syndrome family members, we recommend pre-symptomatic MMR gene mutation analysis in order to identify high risk individuals for colonoscopy surveillance.

摘要

背景

林奇综合征(或 HNPCC)是一种结直肠癌综合征,由 DNA 错配修复(MMR)基因 hMLH1、hMSH2、hMSH6 或 hPMS2 中的种系突变引起。hMLH1 和 hMSH2 的突变最为常见。在这里,我们旨在确定 MMR 基因突变携带者的癌症风险,此外,还确定了有和没有 MMR 基因突变的中国林奇综合征家族成员进行结肠镜检查监测的效果。

方法

最近在中国北方建立了一个林奇综合征家族登记处,包含 106 个家族。详细收集了每个家庭的系谱数据,并进行了 hMLH1 和 hMSH2 基因突变分析。从其中 42 个家庭的先证者中鉴定出种系突变,并对这些 42 个家庭的每个成员进行了额外的遗传分析,以确定突变和非突变携带者。在包括的家庭成员中,有 180 人接受了结肠镜检查,其余病例未接受结肠镜检查。

结果

总体而言,54.8%的林奇综合征家族成员携带 MMR 基因突变,与非突变携带者相比,这些突变携带者的结直肠癌和其他林奇综合征相关癌症风险显著更高。70 岁时所有与林奇综合征相关的癌症累积风险分别为 hMLH1 和 hMSH2 突变携带者的 93.8%和 81.7%和 93.1%,分别为结直肠癌。而在 102 名突变携带者中有 43 名(42.2%)表现出显著的结肠镜检查结果,包括 10 例结直肠癌,而 78 名非突变携带者均无显著发现,也未发现癌症。此外,在突变携带者中,结肠镜检查监测比非监测组发现更多的早期癌症(70.0%比 36.5%,p<0.01)。

结论

在林奇综合征家族成员中,我们建议进行 MMR 基因突变的无症状前分析,以确定需要进行结肠镜检查监测的高危个体。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验